REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/01/2025
Back to search
Official data from USPTO
ADHANSIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
12/02/2025
Trademark type
Word
Nice classes
5, 44
Filing date
05/08/2017
Registration date
12/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/01/2020
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
13
Owner location
STAMFORD, CT
Examiner
SPILS,CAROL A
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
P. L. (pessoa física)
P. P. (pessoa física)
Representatives
Fara S. Sunderji Dorsey & Whitney LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous systemattention deficit disorderattention deficit hyperactivity disorderhyperactivitycognitive impairment disordersmood disordersoppositional defiance disorderconduct disorderlearning disabilitiesautism spectrum disordertic disordersbinge eating and obsessive eating disordersanxiety disorderssubstance abuse disordersdepressionpsychosis
Class 44
Providing health information to health care providers about pharmaceutical preparationsincluding pharmaceutical preparations for the treatment of diseases and disorders of the central nervous systemvia a websitethe Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparationsincluding pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
Publications
History of USPTO decisions and trademark events.
49 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/01/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/27/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/09/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/09/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/08/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/08/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/28/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/25/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/22/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/08/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/08/2019
CNSI
SUSPENSION INQUIRY WRITTEN
08/08/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/20/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/13/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/13/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/08/2019
GNSL
LETTER OF SUSPENSION E-MAILED
02/08/2019
CNSL
SUSPENSION LETTER WRITTEN
02/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/17/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/17/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/16/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/18/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/18/2018
CNSI
SUSPENSION INQUIRY WRITTEN
07/18/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/13/2018
ALIE
ASSIGNED TO LIE
07/13/2018
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/29/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/03/2018
GNSL
LETTER OF SUSPENSION E-MAILED
02/03/2018
CNSL
SUSPENSION LETTER WRITTEN
02/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/29/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/29/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/05/2017
GNRT
NON-FINAL ACTION E-MAILED
08/05/2017
CNRT
NON-FINAL ACTION WRITTEN
08/05/2017
DOCK
ASSIGNED TO EXAMINER
08/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2017
NWAP
NEW APPLICATION ENTERED
05/11/2017
Continuous trademark protection
Get notified about every new filing that threatens ADHANSIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.